ARTICLE | Clinical News
Biomune preclinical data
November 14, 1994 8:00 AM UTC
BIME (Salt Lake City) announced preliminary results of an animal study that showed an 11 percent reduction in the growth rate of prostate cancer cells implanted in rats.
Male rats were injected twice with a million prostate tumor cells. Four different doses and placebo were given eight days after the implant. The drug was given for a week. ...